CHADIS Joins Allscripts Developer Program To Provide Complete Online Screening Tools And Decision Support For Pediatricians

 

BALTIMORE , Dec. 18, 2014 -- Total Child Health, the creator of CHADIS, has joined the Allscripts Developer Program and is now offering a certified solution for Allscripts TouchWorks® EHR that utilizes Allscripts Open APIs.  The integration of CHADIS with TouchWorks allows access to all of the screening tools delivered by CHADIS including the major validated development and autism screening tools (e.g. ASQ-3, M-CHAT-R), Early Childhood Screening Assessment and others that collect information on nutrition, sleep, feeding, toileting, exercise, safety, and EPSDT health risks.

CHADIS:

  • Provides Enhanced Patient Care by enabling families to share concerns and goals before the visit
  • Fulfills American Academy of Pediatrics (AAP) recommendations and Bright Futures guidelines for routine care
  • Uses evidence-based tools to accurately identify problems
  • Improves Office Workflow with Pre-visit data collection allowing the clinician to focus on addressing patient concerns and visit agenda
  • May increase Practice Income with developmental and health screening tools eligible for 96110 and 99420 billing to insurance or Medicaid as well as providing documentation for higher-level codes
  • Part 4 Maintenance of Certification Assistance

"With CHADIS, users can seamlessly integrate delivery and assessment of validated preventive care and disease-specific screening tools into their daily workflow.  Providers can take advantage of automated ordering of age-specific screening questionnaires for upcoming routine well visits in addition to ordering questionnaires manually from within TouchWorks.  Since results are passed as discrete data, they can be cited into an encounter note and be captured and tracked within customized flowsheets,"said Dr. Everett Weiss, Sr. Clinical Content Director, Allscripts.  "Allscripts certification of CHADIS showcases our commitment to Pediatric providers and our ability to extend Allscripts TouchWorks EHR core functionality with complementing solutions using Allscripts Open platform." More about CHADIS can be found on the Allscripts Application Store.  For a custom quote and demo, please contact allscripts@chadis.com.

SOURCE Total Child Health

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.